Page 7 - இடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Buzz Show: Exela Technologies, Inc (NASDAQ: XELA) Rollout of EON, Robotic Processing | Financial Buzz The Buzz Show: Exela Technologies, Inc (NASDAQ: XELA) Rollout of EON, Robotic Processing

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Exela Technologies, Inc. Surges Amid Providing EON Automation Platform to Health Insurance Company” Exela Technologies, Inc. (NASDAQ: XELA) surged over 51% in premarket trading after the company announced the rollout of EON, Exela’s Robotic Process Automation platform for a large health insurance company. This effort accelerates the digital transformation efforts for a major insurer by automating repetitive manual tasks, and is currently utilized by several customers across multiple industries including Banking, Finance & Accounting and the Public Sector. Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience.

Exela technologies incAutomation platform to health insurance companyBuzz showFeaturing our corporate news recapSurges amid providingHealth insuranceRobotic process automationExela technologiesபுழ்ழ் காட்டுஇடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப்ஆரோக்கியம் காப்பீடுரோபோடிக் ப்ரோஸெஸ் ஆட்டோமேஷன்

Buzz on the Street Show: TD Holdings, Inc (NASDAQ: GLG) Acquires Digital Software Copyrights | Financial Buzz Buzz on the Street Show: TD Holdings, Inc (NASDAQ: GLG) Acquires Digital Software Copyrights

Buzz on the Street Show: TD Holdings, Inc (NASDAQ: GLG) Acquires Digital Software Copyrights | Financial Buzz Buzz on the Street Show: TD Holdings, Inc (NASDAQ: GLG) Acquires Digital Software Copyrights
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

Tongdow hainanYunfeihu iot co ltdTongdow group co ltdTd holdings incTongdow hainan data technology co ltdStreet showFeaturing our corporate news recapCompletes acquisitionட் ஹோல்டிங்ஸ் இன்க்தெரு காட்டுஇடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப்

The Buzz Show: Bionano Genomics, Inc (NASDAQ: BNGO) Joins US Small-Cap Russell 2000® Index | Financial Buzz The Buzz Show: Bionano Genomics, Inc (NASDAQ: BNGO) Joins US Small-Cap Russell 2000® Index

Posted on FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Bionano Genomics, Inc. up 6% after Becoming a Member of US Small-Cap Russell 2000® Index” Bionano Genomics, Inc. (NASDAQ: BNGO) gained over 6% in premarket trading after the Company said it was added as a member of the US small-cap Russell 2000® Index, effective as of the Market open on June 28th. Membership in the Russell 2000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index, with the indexes widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.

Bionano saphyrBionano genomics incBuzz showFeaturing our corporate news recapCap russellBionano genomicsபுழ்ழ் காட்டுஇடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப்தொப்பி ரஸ்ஸல்

The Buzz Show: Intellia Therapeutics, Inc (NASDAQ: NTLA) Positive Gene Editing Data | Financial Buzz The Buzz Show: Intellia Therapeutics, Inc (NASDAQ: NTLA) Positive Gene Editing Data

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Intellia Therapeutics, Inc. Surges Following Positive Gene Editing Data” Intellia Therapeutics, Inc. (NASDAQ: NTLA) surged over 59% in premarket trading after the Company and Regeneron Pharmaceuticals announced positive interim data from an ongoing Phase 1 clinical study of their lead in vivo genome editing candidate, NTLA-2001. The Phase 1 study of a single-dose treatment for ATTR is evaluating the first CRISPR/Cas9-based therapy candidate to be administered systemically, via intravenous infusion, for precision editing of a gene in a target tissue in humans. Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics using CRISPR/Cas9 technology. To fully realize the transformative potential of CRISPR/Cas9, Intellia is pursuing two primary approaches. The company’s

Regeneron pharmaceuticalsIntellia therapeutics incBuzz showFeaturing our corporate news recapSurges following positive gene editingIntellia therapeuticsபுழ்ழ் காட்டுஇடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப்

Buzz on the Street Show: Greenland Technologies (NASDAQ: GTEC) to Present at New Energy Conference

Buzz on the Street Show: Greenland Technologies (NASDAQ: GTEC) to Present at New Energy Conference
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

Nomura industrials new energy dayEnergy conferenceGreenland technologies holding corporationStreet showFeaturing our corporate news recapNew energyTechnologies holding corporationNew energy dayஆற்றல் மாநாடுகிரீன்லாந்து தொழில்நுட்பங்கள் வைத்திருத்தல் நிறுவனம்தெரு காட்டுஇடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப்புதியது ஆற்றல்தொழில்நுட்பங்கள் வைத்திருத்தல் நிறுவனம்